CGA
XBI icon

Crescent Grove Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.61M Sell
79,675
-4,440
-5% -$368K 0.64% 35
2025
Q1
$6.82M Sell
84,115
-7,530
-8% -$611K 0.71% 31
2024
Q4
$8.25M Sell
91,645
-5,573
-6% -$502K 0.82% 29
2024
Q3
$9.61M Sell
97,218
-6,285
-6% -$621K 0.98% 23
2024
Q2
$9.6M Sell
103,503
-10,331
-9% -$958K 1.05% 24
2024
Q1
$10.8M Sell
113,834
-6,927
-6% -$657K 1.13% 22
2023
Q4
$10.8M Sell
120,761
-2,780
-2% -$248K 1.2% 21
2023
Q3
$9.02M Sell
123,541
-6,494
-5% -$474K 1.12% 21
2023
Q2
$10.8M Sell
130,035
-517
-0.4% -$43K 1.16% 21
2023
Q1
$9.95M Buy
130,552
+5,048
+4% +$385K 1.15% 21
2022
Q4
$10.4M Sell
125,504
-11,061
-8% -$918K 1.08% 22
2022
Q3
$10.8M Buy
136,565
+1,557
+1% +$123K 1.25% 17
2022
Q2
$10M Buy
135,008
+3,820
+3% +$284K 1.06% 19
2022
Q1
$11.8M Buy
131,188
+22,576
+21% +$2.03M 1.15% 18
2021
Q4
$12.2M Sell
108,612
-10,735
-9% -$1.2M 1.14% 19
2021
Q3
$15M Buy
119,347
+20,769
+21% +$2.61M 1.59% 14
2021
Q2
$13.3M Buy
98,578
+11,842
+14% +$1.6M 1.4% 15
2021
Q1
$11.8M Sell
86,736
-1,433
-2% -$194K 1.38% 16
2020
Q4
$12.4M Buy
88,169
+3,095
+4% +$436K 1.62% 13
2020
Q3
$9.48M Buy
85,074
+1,894
+2% +$211K 1.89% 12
2020
Q2
$9.31M Sell
83,180
-2,310
-3% -$259K 1.97% 11
2020
Q1
$6.62M Sell
85,490
-4,043
-5% -$313K 1.47% 12
2019
Q4
$8.52M Sell
89,533
-3,841
-4% -$365K 1.48% 12
2019
Q3
$7.12M Sell
93,374
-20,655
-18% -$1.57M 1.37% 14
2019
Q2
$10M Sell
114,029
-2,768
-2% -$243K 1.88% 8
2019
Q1
$10.6M Buy
116,797
+12,878
+12% +$1.17M 2.17% 7
2018
Q4
$7.46M Sell
103,919
-35,533
-25% -$2.55M 1.59% 11
2018
Q3
$13.4M Buy
139,452
+5,208
+4% +$499K 2.89% 6
2018
Q2
$12.8M Buy
134,244
+4,917
+4% +$468K 3.17% 6
2018
Q1
$11.3M Buy
129,327
+11,057
+9% +$970K 2.78% 6
2017
Q4
$10M Buy
118,270
+26,290
+29% +$2.23M 2.52% 7
2017
Q3
$7.96M Buy
91,980
+3,948
+4% +$342K 2.04% 8
2017
Q2
$6.79M Buy
+88,032
New +$6.79M 1.96% 9